These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11060714

  • 1. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
    Heydorn WE.
    Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM.
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [Abstract] [Full Text] [Related]

  • 6. Benefit-risk assessment of zaleplon in the treatment of insomnia.
    Barbera J, Shapiro C.
    Drug Saf; 2005 Jan; 28(4):301-18. PubMed ID: 15783240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety of zaleplon in the treatment of insomnia.
    Israel AG, Kramer JA.
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.
    Sanger DJ, Morel E, Perrault G.
    Eur J Pharmacol; 1996 Oct 10; 313(1-2):35-42. PubMed ID: 8905326
    [Abstract] [Full Text] [Related]

  • 10. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R, Rüther E, Farr I, Emilien G, Salinas E.
    J Clin Psychiatry; 1999 Aug 10; 60(8):536-44. PubMed ID: 10485636
    [Abstract] [Full Text] [Related]

  • 11. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Noguchi H, Kitazumi K, Mori M, Shiba T.
    J Pharmacol Sci; 2004 Mar 10; 94(3):246-51. PubMed ID: 15037809
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of insomnia with zaleplon, a novel sleep medication.
    Doghramji PP.
    Int J Clin Pract; 2001 Jun 10; 55(5):329-34. PubMed ID: 11452683
    [Abstract] [Full Text] [Related]

  • 14. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM, von Moltke LL, Greenblatt DJ.
    CNS Drugs; 2003 Jun 10; 17(7):513-32. PubMed ID: 12751920
    [Abstract] [Full Text] [Related]

  • 15. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
    Rush CR, Frey JM, Griffiths RR.
    Psychopharmacology (Berl); 1999 Jul 10; 145(1):39-51. PubMed ID: 10445371
    [Abstract] [Full Text] [Related]

  • 16. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
    Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L.
    Drug Saf; 2003 Jul 10; 26(4):261-82. PubMed ID: 12608888
    [Abstract] [Full Text] [Related]

  • 17. Zaleplon for insomnia.
    Med Lett Drugs Ther; 1999 Oct 08; 41(1063):93-4. PubMed ID: 10535052
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.
    Noguchi H, Kitazumi K, Mori M, Shiobara Y, Shiba T.
    J Pharmacol Sci; 2003 Oct 08; 93(2):204-9. PubMed ID: 14578589
    [Abstract] [Full Text] [Related]

  • 20. Management of insomnia--the role of zaleplon.
    Richardson GS, Roth T, Kramer JA.
    MedGenMed; 2002 Mar 14; 4(1):9. PubMed ID: 11965211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.